InvestorsHub Logo
Post# of 252528
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: genisi post# 76056

Tuesday, 10/27/2009 3:12:18 PM

Tuesday, October 27, 2009 3:12:18 PM

Post# of 252528
Late-Stage Products Looking for a Home

Criteria for inclusion:
a) Program is in phase-3 or beyond and is non-partnered.
b) Company does not have enough cash to bring the product to market.

Edits: Removed – MDVN (MDV-3100 partnered with Astellas)
  

Stock Product Stage Comments
----- --------------- --------------------- -----------------------------
ARNA Lorcaserin Phase 3 Obesity
BPAX Libigel Phase 3 ~2010 Submit Adequate Safety
CHTP Droxidopa Pivotal Phase III Orthostatic hypotension. Results expected 02/09.
CRGB Abiraterone Phase 3 Prostate cancer
DYAX DX-88 for HAE BLA filed 9/24/08 (CABG indication partnered w CBST)
GNVC TNFerade Pivotal Phase III Pancreatic cancer
JAV Dyloject Phase III Approved in UK. Post operative Pain (injectable)
JAV Ketamine Phase III Acute moderate-to-severe pain (intranasal)
OREX Contrave Phase 3 Obesity
OXGN Zybrestat Phase 3 Anaplastic thyroid cancer
Pharming Rhucin Pre-BLA Rejected in EU
Protalix prGCD Phase III Gaucher's disease. Not enough cash for a commercial infrastructure
RPRX Proellex Phase 3 Uterine fibroids
SVNT Puricase BLA filed Treatment refratory gout

Procedure for Updating Table

1. Copy the text in this post into a word processor.

2. Using a monospace font (e.g. Courier) to facilitate tabular
alignment, make your additions and modifications, inserting
them in the table in alphabetical order. NOTE: use spaces
rather than tab characters.

3. Add a brief note in the “Edits:” line atop the table to
describe your changes.

4. Insert the iHub formatting directives: Put [ pre ] at the
beginning of the table without the surrounding spaces, and
put [ /pre ] at the end of the table without the surrounding
spaces.

5. Post your text as a reply to this message.

Thank you for your cooperation.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.